Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

53.29 -0.25 (-0.47%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna Inc

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Are We Heading for a Recession? Here's What Investors Should Do.
The stock market has rallied since the start of the year. 
Via The Motley Fool
Week In Review: Billion Dollar Deals - Moderna’s Shanghai Investment And F-Star’s Takeda Collaboration
F-star Therapeutics formed a license agreement with Takeda to develop Fcab domains aimed at undisclosed immuno-oncology targets. Also, Brii Bio signed a global license to an HBV immunotherapeutic... 
Via Talk Markets
A Big Test Is Looming for Pfizer, Moderna, and Novavax
Investors in these companies should brace for some potentially underwhelming results this year. 
Via The Motley Fool
$1 Billion Deal For Moderna To Expand Product Pipeline in China
Moderna is looking to diversify its falling U.S. product line, a $1 billion investment in China may act as the catalyst pushing the company's valuation higher 
Via MarketBeat
Topics ETFs Economy
Exposures COVID-19 Economy
3 Value Stocks to Consider Selling Before They Do Your Portfolio In
Looking to protect your portfolio? Learn the art of portfolio management by selling bad value stocks and identifying the right time to sell. 
Via InvestorPlace
Is Moderna Heading for a Critical Moment?
Moderna predicts the coronavirus vaccine market will follow that of the flu shot. 
Via The Motley Fool
Moderna Submits Regulatory Application to the European Medicines Agency for Its Updated COVID-19 Vaccine
Via ACCESSWIRE
Moderna Unusual Options Activity
Via Benzinga
What's Going On With Moderna Stock?
Moderna, Inc. (NASDAQ: MRNA) shares traded higher today after reports suggested the company signed a memorandum of understanding and land collaboration agreement to research, develop and manufacture... 
Via Benzinga
Moderna Strikes mRNA Drug Pact With Chinese Authorities: Report
Moderna Inc (NASDAQ: MRNA) reportedly struck a deal with Chinese authorities to research, develop, and manufacture messenger RNA (mRNA) medicines in the country. 
Via Benzinga
InvestorNewsBreaks – Cisco Systems Inc. (NASDAQ: CSCO) Featured in Yahoo! Finance Article
Via Investor Brand Network
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
EXCLUSIVE: Top 10 Most-Searched Tickers On Benzinga Pro In Q2 — Tesla, Nvidia, C3.ai, Meta Platforms, Microsoft And More
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to get the latest breaking news on the overall market and individual tickers. 
Via Benzinga
Analyst Ratings for Moderna
Via Benzinga
Moderna Initiates Regulatory Application Process Seeking Approval For Its RSV Vaccine In Older Adults
Moderna Inc (NASDAQ: MRNA) provided an update on regulatory submissions for the mRNA-1345 vaccine to prevent RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease in  
Via Benzinga
Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345
Via ACCESSWIRE
CarMax, Walmart And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by more than 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Moderna Seeks European Nod For Updated COVID-19 Vaccine Shot To Tackle New Dominant Strain
Moderna Inc (NASDAQ: MRNA) submitted a regulatory application to the European Medicines Agency (EMA) for its updated COVID-19 vaccine encoding the spike protein for the XBB.1.5  
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Moderna: Declining Performance And Relative Weakness
Moderna's value has declined by over 75% from its peak as the world moves on from the COVID-19 pandemic, leading to concerns about its investment appeal. 
Via MarketBeat
Topics ETFs
Exposures COVID-19
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Pharma Stocks That Have Big Investors Running for the Exit
Hedge funds, institutional investors and company insiders have been dumping shares of these risky pharma stocks. 
Via InvestorPlace
How to Invest $10,000 -- No Matter What the Market is Doing
You can apply these tips to investing $10,000 -- or any amount of money. 
Via The Motley Fool
Steve Weiss Once Predicted Moderna Stock Would Rise 500% And Trade Like Amazon: Now He's Selling As The CEO Dumps Shares
Short Hills Capital's Steve Weiss once predicted Moderna Inc (NASDAQ: MRNA) shares would make an Amazon-like move. 
Via Benzinga
Moderna Stock Price Forecast: UBS Sees A 60% Upside
Moderna stock is currently down about 40% versus its year-to-date high. 
Via Talk Markets
Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics
As the emergency phase of the COVID-19 pandemic draws to a close, the COVAX initiative, run by Gavi, the WHO, and CEPI, reportedly has $2.6 billion left over that could be used to prepare for other... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
Via Benzinga
Moderna Pipeline For Any Vaccine Beyond Covid Is 'Underappreciated,' Analyst Says
Shares of Moderna Inc (NASDAQ: MRNA) rose in early trading on Monday, just days after the pharma company submitted an application to the Food and Drug Administration (FDA) for the 
Via Benzinga
Amazon, Marriott And 2 Other Stocks Insiders Are Selling
The S&P 500 closed lower on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Wall Street Says This Beaten-Down Stock May Climb Nearly 78%. Is That Too Optimistic?
Can former high-flyer Moderna soar again? 
Via The Motley Fool
6 Director Elections In 2023 That Were Surprisingly Close
Several top companies had close director elections this year, indicating that investors are unsatisfied with incumbent leadership. We could see an increased rate of shareholder activism if markets... 
Via Talk Markets
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.